TheraRadar
Data updated: May 26, 2026

TRIFERIC AVNU (ferric pyrophosphate citrate)

Other Approved 2020-03-27
Jump to: Indications Approvals Trials Competitors Safety Patents
1
Indication
--
Phase 3 Trials
6
Years on Market

Details

Status
Discontinued
First Approved
2020-03-27
Patent Cliff
2029

Pro Metrics

Patent cliff and revenue data

Unlock with Pro
Routes
INTRAVENOUS
Dosage Forms
SOLUTION

Companies

ROCKWELL MEDICAL INC
Active Ingredient: FERRIC PYROPHOSPHATE CITRATE

TRIFERIC AVNU Approval History

2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
2 FDA actions from 2020 to 2023
Jul 2023 SUPPL
Label · Labeling
FDA Letter Label
Mar 2020 ORIGINAL
New Form · Type 3 - New Dosage Form
FDA Letter Label

What TRIFERIC AVNU Treats

1 FDA approvals

Originally approved for its first indication in 2020 .

  • Other (1)
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT04689932 results posted RMFPC-ISS002 Ph 4 completed Triferic AVNU Infusion Via Freedom Pump During Hemodialysis
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TRIFERIC AVNU FDA Label Details

View full patent landscape →
1 OB patents · 1 families · 14 international docs across 11 countries

TRIFERIC AVNU Patents & Exclusivity

Latest Patent: Apr 2029

Patents (1 active)

US7816404 Expires Apr 17, 2029
Source: FDA Orange Book

Pro Intelligence Preview

Deep insights for TRIFERIC AVNU

Revenue Insights

  • • Quarterly revenue tracking
  • • Historical trend analysis

Patent Timeline

  • • Cliff: 2029
  • • 1 active patents

Trial Analysis

  • • Clinical trial tracking
  • • Development stage analysis

Competitive Landscape

  • • Competitor tracking
  • • Same target/indication analysis
Unlock Full Intelligence

Full approval history • All patents • Revenue trends • Competitor analysis

Data Sources

FDA Approval: NDA212860 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.